53 related articles for article (PubMed ID: 2597385)
1. AIDS virus bred in mice.
Hemenway CG
Dent Today; 1989 Mar; 8(2):10, 12. PubMed ID: 2597385
[No Abstract] [Full Text] [Related]
2. Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy.
Dickie P; Roberts A; Uwiera R; Witmer J; Sharma K; Kopp JB
Virology; 2004 Apr; 322(1):69-81. PubMed ID: 15063118
[TBL] [Abstract][Full Text] [Related]
3. Infection of HIV-1 transgenic mice with Mycobacterium avium induces the expression of infectious virus selectively from a Mac-1-positive host cell population.
Doherty TM; Chougnet C; Schito M; Patterson BK; Fox C; Shearer GM; Englund G; Sher A
J Immunol; 1999 Aug; 163(3):1506-15. PubMed ID: 10415053
[TBL] [Abstract][Full Text] [Related]
4. Transgenic models of HIV-1.
Klotman PE; Rappaport J; Ray P; Kopp JB; Franks R; Bruggeman LA; Notkins AL
AIDS; 1995 Apr; 9(4):313-24. PubMed ID: 7794536
[TBL] [Abstract][Full Text] [Related]
5. Activation of HIV transcription by human foamy virus in transgenic mice.
Marino S; Kretschmer C; Brandner S; Cavard C; Zider A; Briand P; Isenmann S; Wagner EF; Aguzzi A
Lab Invest; 1995 Jul; 73(1):103-10. PubMed ID: 7603032
[TBL] [Abstract][Full Text] [Related]
6. The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice.
Prakash O; Zhang P; Xie M; Ali M; Zhou P; Coleman R; Stoltz DA; Bagby GJ; Shellito JE; Nelson S
Alcohol Clin Exp Res; 1998 Dec; 22(9):2043-9. PubMed ID: 9884149
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 in the developing CNS: developmental differences in gene expression.
Buzy JM; Lindstrom LM; Zink MC; Clements JE
Virology; 1995 Jul; 210(2):361-71. PubMed ID: 7618273
[TBL] [Abstract][Full Text] [Related]
8. AIDS cardiomyopathy: physiological, molecular, and biochemical studies in the transgenic mouse.
Lewis W
Ann N Y Acad Sci; 2001 Nov; 946():46-56. PubMed ID: 11762995
[TBL] [Abstract][Full Text] [Related]
9. In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice.
Hanna Z; Priceputu E; Kay DG; Poudrier J; Chrobak P; Jolicoeur P
Virology; 2004 Oct; 327(2):273-86. PubMed ID: 15351215
[TBL] [Abstract][Full Text] [Related]
10. Building a small-animal model for AIDS, block by block.
Cohen J
Science; 2001 Aug; 293(5532):1034-6. PubMed ID: 11498560
[No Abstract] [Full Text] [Related]
11. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice.
Vogel J; Hinrichs SH; Reynolds RK; Luciw PA; Jay G
Nature; 1988 Oct; 335(6191):606-11. PubMed ID: 2845275
[TBL] [Abstract][Full Text] [Related]
12. Aberrant regulation of cytokines in HIV-1 TAT72-transgenic mice.
Garza HH; Prakash O; Carr DJ
J Immunol; 1996 May; 156(10):3631-7. PubMed ID: 8621896
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice.
Prakash O; Rodriguez VE; Tang ZY; Zhou P; Coleman R; Dhillon G; Shellito JE; Nelson S
Alcohol Clin Exp Res; 2001 Mar; 25(3):450-6. PubMed ID: 11290858
[TBL] [Abstract][Full Text] [Related]
14. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
Azad AA
Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
[TBL] [Abstract][Full Text] [Related]
15. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
[TBL] [Abstract][Full Text] [Related]
17. [Linking Nef with the immunological and virological determinants of AIDS].
Gómez-Icazbalceta G; Larralde C
Rev Invest Clin; 2009; 61(3):243-51. PubMed ID: 19736813
[TBL] [Abstract][Full Text] [Related]
18. Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice.
Singhal PC; Sharma P; Loona R; Gibbons N; Franki N; Klotman PE
J Investig Med; 1998 Aug; 46(6):297-302. PubMed ID: 9737092
[TBL] [Abstract][Full Text] [Related]
19. Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice.
Santoro TJ; Bryant JL; Pellicoro J; Klotman ME; Kopp JB; Bruggeman LA; Franks RR; Notkins AL; Klotman PE
Virology; 1994 May; 201(1):147-51. PubMed ID: 7909972
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
